Petros pharmaceuticals announces reverse stock split

Common stock will begin trading on split-adjusted basis on december 1, 2022 new york, ny / accesswire / november 30, 2022 / petros pharmaceuticals, inc. ("petros" or "the company") (nasdaq:ptpi), a leading provider of therapeutics for men's health, today announced that it intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share for every 10 pre-split shares. the reverse stock split will become effective at 4:05 p.m.
PTPI Ratings Summary
PTPI Quant Ranking